Skip to main content
Erschienen in:

06.11.2019 | Review

Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics

verfasst von: Khaled Y. Elbanna, Korosh Khalili, Martin O’Malley, Tanya Chawla

Erschienen in: Abdominal Radiology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Extension of tumor tissue within a vein is a recognized prognostic factor in abdominal malignancy because of its influence on tumor staging and selection of therapeutic management. With the advent of newer surgical techniques, and variable treatment strategies, imaging plays a crucial role in categorizing patients according to the tumor resectability and vascular reconstruction techniques during surgery. Understanding the clinical impact of tumor thrombus increases the awareness of the radiologist about the key findings in tumor staging and decision-making of surgical approach. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) can be used individually and in combination to accurately assess the tumor thrombus. In our pictorial review, we will discuss the imaging findings and clinical consequences of tumor thrombosis in abdominal malignancies, including hepatocellular carcinoma, pancreatic neuroendocrine tumor, renal cancer, and adrenal cortical carcinoma.
Literatur
1.
Zurück zum Zitat Yerdel MA, Gunson B, Mirza D, et al. (2000) PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION: Risk Factors, Screening, Management, and Outcome1. Transplantation 69:1873–1881CrossRef Yerdel MA, Gunson B, Mirza D, et al. (2000) PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION: Risk Factors, Screening, Management, and Outcome1. Transplantation 69:1873–1881CrossRef
4.
Zurück zum Zitat Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 77:2217–2222 Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 77:2217–2222
5.
Zurück zum Zitat Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery 233(3):379CrossRef Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery 233(3):379CrossRef
9.
Zurück zum Zitat Portolani N, Coniglio A, Ghidoni S, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications 243:229 Portolani N, Coniglio A, Ghidoni S, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications 243:229
10.
Zurück zum Zitat Piscaglia F, Gianstefani A, Ravaioli M, et al (2010) Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinom for liver transplantation. Liver Transpl 16:NA–NA. https://doi.org/10.1002/lt.22044 Piscaglia F, Gianstefani A, Ravaioli M, et al (2010) Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinom for liver transplantation. Liver Transpl 16:NA–NA. https://​doi.​org/​10.​1002/​lt.​22044
12.
Zurück zum Zitat Yamada R, Sato M, Kawabata M, et al. (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401CrossRef Yamada R, Sato M, Kawabata M, et al. (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401CrossRef
13.
Zurück zum Zitat Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198:33–40CrossRef Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198:33–40CrossRef
14.
Zurück zum Zitat Lee H-S, Kim JS, Choi IJ, et al. (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 79:2087–2094 Lee H-S, Kim JS, Choi IJ, et al. (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 79:2087–2094
19.
Zurück zum Zitat Jha RC, Khera SS, Kalaria AD (2018) Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. American Journal of Roentgenology 211(1):14–24CrossRef Jha RC, Khera SS, Kalaria AD (2018) Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. American Journal of Roentgenology 211(1):14–24CrossRef
20.
Zurück zum Zitat Ricci P, Cantisani V, Biancari F, et al. (2000) CONTRAST-ENHANCED COLOR DOPPLER US IN MALIGNANT PORTAL VEIN THROMBOSIS. Acta radiologica 41:470–473CrossRef Ricci P, Cantisani V, Biancari F, et al. (2000) CONTRAST-ENHANCED COLOR DOPPLER US IN MALIGNANT PORTAL VEIN THROMBOSIS. Acta radiologica 41:470–473CrossRef
21.
Zurück zum Zitat Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in Medicine and Biology 39:187–210CrossRef Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in Medicine and Biology 39:187–210CrossRef
23.
Zurück zum Zitat Sorrentino P, D’Angelo S, Tarantino L, et al. (2009) Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World Journal of Gastroenterology: WJG 15:2245CrossRef Sorrentino P, D’Angelo S, Tarantino L, et al. (2009) Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World Journal of Gastroenterology: WJG 15:2245CrossRef
24.
Zurück zum Zitat Piscaglia F, Wilson SR, Lyshchik A, et al. (2017) American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall in der Medizin-European Journal of Ultrasound 38:320–324CrossRef Piscaglia F, Wilson SR, Lyshchik A, et al. (2017) American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall in der Medizin-European Journal of Ultrasound 38:320–324CrossRef
25.
Zurück zum Zitat Wilson SR, Lyshchik A, Piscaglia F, et al. (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Contrast-enhanced ultrasound of malignant liver lesions 43:127–142 Wilson SR, Lyshchik A, Piscaglia F, et al. (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Contrast-enhanced ultrasound of malignant liver lesions 43:127–142
26.
Zurück zum Zitat Goettler CE, Stallion A, Grisoni ER, Dudgeon DL (2002) Delayed hemorrhage after blunt hepatic trauma: case report. Journal of Trauma and Acute Care Surgery 52:556–559CrossRef Goettler CE, Stallion A, Grisoni ER, Dudgeon DL (2002) Delayed hemorrhage after blunt hepatic trauma: case report. Journal of Trauma and Acute Care Surgery 52:556–559CrossRef
28.
Zurück zum Zitat Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. American Journal of Roentgenology 168:719–723CrossRef Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. American Journal of Roentgenology 168:719–723CrossRef
30.
Zurück zum Zitat Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22:2178–2185CrossRef Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22:2178–2185CrossRef
32.
Zurück zum Zitat Ahn J-H, Yu J-S, Cho E-S, et al. (2016) Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol 17:533–540CrossRef Ahn J-H, Yu J-S, Cho E-S, et al. (2016) Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol 17:533–540CrossRef
34.
Zurück zum Zitat Birnbaum DJ, Turrini O, Ewald J, et al. (2014) Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. European Journal of Surgical Oncology (EJSO) 40:1564–1571CrossRef Birnbaum DJ, Turrini O, Ewald J, et al. (2014) Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. European Journal of Surgical Oncology (EJSO) 40:1564–1571CrossRef
35.
Zurück zum Zitat Wang S-E, Su C-H, Kuo Y-J, et al. (2011) Comparison of Functional and Nonfunctional Neuroendocrine Tumors in the Pancreas and Peripancreatic Region. Pancreas 40:253CrossRef Wang S-E, Su C-H, Kuo Y-J, et al. (2011) Comparison of Functional and Nonfunctional Neuroendocrine Tumors in the Pancreas and Peripancreatic Region. Pancreas 40:253CrossRef
36.
Zurück zum Zitat Prakash L, Lee JE, Yao J, et al. (2015) Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 19:2011–2018CrossRef Prakash L, Lee JE, Yao J, et al. (2015) Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 19:2011–2018CrossRef
37.
Zurück zum Zitat Balachandran A, Tamm EP, Bhosale PR, et al. (2012) Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. American Journal of Roentgenology 199:602–608CrossRef Balachandran A, Tamm EP, Bhosale PR, et al. (2012) Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. American Journal of Roentgenology 199:602–608CrossRef
38.
Zurück zum Zitat Robertis RD, Paiella S, Cardobi N, et al. (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Contrast-enhanced ultrasound of malignant liver lesions 43:613–619 Robertis RD, Paiella S, Cardobi N, et al. (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Contrast-enhanced ultrasound of malignant liver lesions 43:613–619
39.
Zurück zum Zitat Semelka RC, Custodio CM, Balci NC, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 11:141–148CrossRef Semelka RC, Custodio CM, Balci NC, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 11:141–148CrossRef
40.
Zurück zum Zitat Capitanio U, Montorsi F (2016) Renal cancer. The Lancet 387:894–906CrossRef Capitanio U, Montorsi F (2016) Renal cancer. The Lancet 387:894–906CrossRef
41.
Zurück zum Zitat Psutka SP, Boorjian SA, Thompson RH, et al. (2015) Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int 116:388–396CrossRef Psutka SP, Boorjian SA, Thompson RH, et al. (2015) Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int 116:388–396CrossRef
42.
Zurück zum Zitat Tilki D, Nguyen HG, Dall’Era MA, et al. (2014) Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European Urology 66:577–583CrossRef Tilki D, Nguyen HG, Dall’Era MA, et al. (2014) Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European Urology 66:577–583CrossRef
43.
Zurück zum Zitat Kondo T, Ikezawa E, Takagi T, et al. (2013) Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience. International Journal of Urology 20:1072–1077CrossRef Kondo T, Ikezawa E, Takagi T, et al. (2013) Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience. International Journal of Urology 20:1072–1077CrossRef
44.
Zurück zum Zitat Dunnick NR (2016) Renal cell carcinoma: staging and surveillance. Contrast-enhanced ultrasound of malignant liver lesions 41:1079–1085 Dunnick NR (2016) Renal cell carcinoma: staging and surveillance. Contrast-enhanced ultrasound of malignant liver lesions 41:1079–1085
45.
Zurück zum Zitat Robins DJ, Small AC, Amin MB, et al. (2017) MP86-17 the 2017 American Joint Committee on Cancer eighth edition cancer staging manual: changes in staging guidelines for cancers of the kidney, renal pelvis and ureter, bladder, and urethra. The Journal of Urology 197:e1163CrossRef Robins DJ, Small AC, Amin MB, et al. (2017) MP86-17 the 2017 American Joint Committee on Cancer eighth edition cancer staging manual: changes in staging guidelines for cancers of the kidney, renal pelvis and ureter, bladder, and urethra. The Journal of Urology 197:e1163CrossRef
51.
Zurück zum Zitat Lawrentschuk N, Gani J, Riordan R, et al. (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96:291–295CrossRef Lawrentschuk N, Gani J, Riordan R, et al. (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96:291–295CrossRef
54.
Zurück zum Zitat Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of Urology 169:5–11CrossRef Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of Urology 169:5–11CrossRef
55.
Zurück zum Zitat Smillie RP, Shetty M, Boyer AC, et al. (2015) Imaging evaluation of the inferior vena cava. RadioGraphics 35:578–592CrossRef Smillie RP, Shetty M, Boyer AC, et al. (2015) Imaging evaluation of the inferior vena cava. RadioGraphics 35:578–592CrossRef
56.
Zurück zum Zitat Chiche L, Dousset B, Kieffer E, Chapuis Y (2006) Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 139:15–27CrossRef Chiche L, Dousset B, Kieffer E, Chapuis Y (2006) Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 139:15–27CrossRef
57.
Zurück zum Zitat Laan DV, Thiels CA, Glasgow A, et al. (2017) Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery 161:240–248CrossRef Laan DV, Thiels CA, Glasgow A, et al. (2017) Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery 161:240–248CrossRef
58.
Zurück zum Zitat Bharwani N, Rockall AG, Sahdev A, et al. (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. American Journal of Roentgenology 196:W706–W714CrossRef Bharwani N, Rockall AG, Sahdev A, et al. (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. American Journal of Roentgenology 196:W706–W714CrossRef
Metadaten
Titel
Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics
verfasst von
Khaled Y. Elbanna
Korosh Khalili
Martin O’Malley
Tanya Chawla
Publikationsdatum
06.11.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02282-y

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.